PELVIC CLINICAL TARGET VOLUME DEFINITION IN HIGH-RISK PROSTATE CANCER USING SENTINEL NODE SPECT AND 18F-FCH PET-CT

被引：0
|
作者：
Vees, H. [1 ]
Steiner, C. [2 ]
Chouiter, A. [3 ]
Dipasquale, G. [1 ]
Zilli, T. [1 ]
Wissmeyer, M. [2 ]
Ratib, O. [2 ]
Buchegger, F. [2 ]
Miralbell, R. [1 ]
机构：
[1] Hop Univ Geneve, Geneva, Switzerland
[2] Hop Univ Geneve, Nucl Med, Geneva, Switzerland
[3] Hop Univ Geneve, Radiol, Geneva, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1155
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [1] TARGET VOLUME DEFINITION IN HIGH RISK PROSTATE CANCER USING SENTINEL NODE SPECT AND 18F-CHOLINE PET-CT
    Vees, H.
    Steiner, Ch
    Chouiter, A.
    Dipasquale, G.
    Wissmeyer, M.
    Ratib, O.
    Buchegger, F.
    Miralbell, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 723 - 723
  • [2] Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18F-choline PET/CT
    Vees, Hansjoerg
    Steiner, Charles
    Dipasquale, Giovanna
    Chouiter, Amine
    Zilli, Thomas
    Velazquez, Michel
    Namy, Sophie
    Ratib, Osman
    Buchegger, Franz
    Miralbell, Raymond
    RADIATION ONCOLOGY, 2012, 7
  • [3] Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT
    Hansjörg Vees
    Charles Steiner
    Giovanna Dipasquale
    Amine Chouiter
    Thomas Zilli
    Michel Velazquez
    Sophie Namy
    Osman Ratib
    Franz Buchegger
    Raymond Miralbell
    Radiation Oncology, 7
  • [4] 18F-FCH PET/CT Staging in Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 30N - +
  • [5] 18F-fluorocholine positron emission tomography-computed tomography (18F-FCH PET/CT) for staging of high-risk prostate cancer patients
    Gauvin, Simon
    Rompre-Brodeur, Alexis
    Chausse, Guillaume
    Anidjar, Maurice
    Bladou, Franck
    Probst, Stephan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (04): : 84 - 91
  • [6] The study of 18F-FDG and 18F-FCH PET/CT in the clinical evaluation of pancreatic cancer
    Cheng, Bing
    Han, Xingmin
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [7] 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Misko, Jolanta
    Dziuk, Miroslaw
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E401 - E403
  • [8] Role of 18F-FCH PET/CT in Detecting Recurrences of Prostate Cancer After Curative Treatments
    Altini, Corinna
    Asabella, Artor Niccoli
    Tramacere, Francesco
    Sardaro, Angela
    Pisani, Antonio Rosario
    Castelluccia, Alessandra
    Rubini, Dino
    Ferrari, Cristina
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2024, 33 (01) : 1 - 10
  • [9] Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
    Ute Ganswindt
    Frank Paulsen
    Stefan Corvin
    Kai Eichhorn
    Stefan Glocker
    Ilse Hundt
    Mattias Birkner
    Markus Alber
    Aristotelis Anastasiadis
    Arnulf Stenzl
    Roland Bares
    Wilfried Budach
    Michael Bamberg
    Claus Belka
    BMC Cancer, 5
  • [10] Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
    Ganswindt, U
    Paulsen, F
    Corvin, S
    Eichhorn, K
    Glocker, S
    Hundt, I
    Birkner, M
    Alber, M
    Anastasiadis, A
    Stenzl, A
    Bares, R
    Budach, W
    Bamberg, M
    Belka, C
    BMC CANCER, 2005, 5 (1)
12345